Advertisement

Psychopharmacology

, Volume 87, Issue 2, pp 141–146 | Cite as

Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome

  • Hemendra N. Bhargava
  • George A. Matwyshyn
Original Investigations

Abstract

The effect of thyrotropin releasing hormone (TRH) were compared with two of its analogs, l-N-(2-oxopiperidin-6-yl-carbonyl)-l-histidyl-l-thiazolidine-4-carboxamide (MK-771) and γ-butyrolactone-4-carboxyl-histidylprolineamide (DN-1417) on the abrupt and naloxone-precipitated abstinence symptoms in morphine-dependent male Swiss-Wester mice. Mice were made physically dependent on morphine by subcutaneous implantation for 3 days of a pellet containing 75 mg morphine free base. Control mice were implanted with placebo pellets. Intracerebral administration of TRH (10 ng-10 μg per mouse) immediately after removal of placebo pellets had no effect on the basal temperature of mice. Mice implanted with morphine pellets exhibited a characteristic hypothermic response following the removal of the pellets. TRH at all doses employed prevented the hypothermia observed during abrupt withdrawal of morphine (pellet removal). DN-1417 and MK-771 (10 ng-10 μg per mouse) on the other hand produced a short lived hyperthermic response in mice from which placebo pellets had been removed. However, both TRH analogs produced long-lasting antagonism of withdrawal hypothermia in mice from which morphine pellets had been removed. TRH and its analogs had no effect on the body weight loss observed during abrupt withdrawal of morphine. Intracerebral administration of 10 μg TRH and its analogs inhibited the naloxone-induced jumping response as evidenced by increases in naloxone ED50 values to elicit this response. It is concluded that TRH and its analogs may be useful in combating some of the withdrawal symptoms in opiate-dependent subjects.

Key words

Mice Morphine abstinence syndrome Dependence Naloxone Hypothermia Body weight loss TRH-MK-771 DN-1417 Peptide hormone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bhargava HN (1977) Rapid induction and quantitation of morphine-dependence in the rat by pellet implantations. Psychopharmacology 52:55–62Google Scholar
  2. Bhargava HN (1978) Effects of methionine-enkephalin and morphine on spontaneous locomotor activity: antagonism by naloxone. Pharmacol Biochem Behav 9:167–171Google Scholar
  3. Bhargava HN (1980a) The effects of thyrotropin releasing hormone and histidyl-proline diketo-piperazine on delta-9-tetrahydrocannabinol induced hypothermia. Life Sci 26:845–849Google Scholar
  4. Bhargava HN (1980b) The effects of thyrotropin releasing hormone on the central nervous system responses to chronic morphine administration. Psychopharmacology 68:185–189Google Scholar
  5. Bhargava HN (1981a) Antagonism of ketamine induced anesthesia and hypothermia by TRH and cyclo(His-Pro). Neuropharmacology 20:699–702Google Scholar
  6. Bhargava HN (1981b) Dissociation of tolerance to the analgesic and hypothermic effects of morphine by using thyrotropin releasing hormone. Life Sci 29:1015–1020Google Scholar
  7. Bhargava HN (1981c) Inhibition of abstinence syndrome in opiate-dependent mice by cyclo(His-Pro). Life Sci 28:1261–1267Google Scholar
  8. Bhargava HN, Matwyshyn GA (1980) Influence of thyrotropin releasing hormone and histidyl-proline diketopiperazine on spontaneous motor activity and analgesia induced by delta-9-tetrahydrocannabinol in the mouse. Eur J Pharmacol 68:185–189Google Scholar
  9. Bhargava HN, Matwyshyn GA, Currie BL, Goebel RJ (1982) Structure-activity relationship studies with hypothalamic peptide hormones II: Effect of thyrotropin releasing hormone analogs on morphine-induced responses in mice. Life Sci 30:711–718Google Scholar
  10. Bhargava HN, Way EL (1972) Acetylcholinesterase inhibition and morphine effects in morphine tolerant and dependent mice. J Pharmacol Exp Ther 183:31–40Google Scholar
  11. Bhargava HN, Way EL (1975) Brain acetylcholine and choline following acute and chronic morphine treatment and during withdrawal. J Pharmacol Exp Ther 194:65–74Google Scholar
  12. Bhargava HN, Yousif DJ, Matwyshyn GA (1983) Interaction of thyrotropin releasing hormone, its metabolites and analogues with endogenous and exogenous opiates. Gen Pharmacol 14:565–570Google Scholar
  13. Bowers CY, Friesen HG, Hwang P, Guyda HJ, Folker K (1971) Prolactin and thyrotropin release in man by synthetic pyroglutamylhistidylprolineamide. Biochem Biophys Res Commun 45:1033–1041Google Scholar
  14. Breese GR, Cott JM, Cooper BR, Prange AJ Jr, Lipton MA, Plotnikoff NP (1975) Effects of thyrotropin releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs. J Pharmacol Exp Ther 193:11–22Google Scholar
  15. Brownstein MJ, Palkovits M, Saavedra JM, Bassiri RM, Utiger RD (1974) Thyrotropin releasing hormone in specific nuclei of rat brain. Science 185:267–269Google Scholar
  16. Hokfelt TK, Fuxe Johansson O, Jeffcoate JL, White N (1975) Distribution of TRH in the central nervous system as revealed by immunohistochemistry. Eur J Pharmacol 34:389–392Google Scholar
  17. Holaday JW, Loh HH, Li CH (1978a) Unique behavioral effects of beta-endorphin and their relationship to thermoregulation and hypothalamic function. Life Sci 22:1525–1536Google Scholar
  18. Holaday JW, Tseng LF, Loh HH, Li CH (1978b) Thyrotropin releasing hormone antagonizes beta endorphin hypothermia and catalepsy. Life Sci 22:1537–1544Google Scholar
  19. Horita A, Carino MA (1981) A comparison of the pharmacological properties of TRH and MK-771. Proc West Pharmacol Soc 24:347–348Google Scholar
  20. Horita A, Carino MA, Chestnut RM (1976) Influence of thyrotropin releasing hormone (TRH) on drug induced narcosis and hypothermia in rabbits. Psychopharmacology 49:57–62Google Scholar
  21. Iwamoto ET, Ho IK, Way EL (1973) Elevation of brain dopamine during naloxone precipitated withdrawal in morphine-dependent mice and rats. J Pharmacol Exp Ther 187:558–567Google Scholar
  22. Kirk RE (1968) Experimental design: Procedure for the behavioral sciences. Brooks Cole, Los AngelesGoogle Scholar
  23. Litchfield JW, Wilcoxon F (1949) A simplified method for evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99–113Google Scholar
  24. Martin BR, Dewey WL, Chau-Pham T, Prange Jr AJ (1977) Interactions of thyrotropin releasing hormone and morphine sulfate in rodents. Life Sci 20:715–722Google Scholar
  25. Metcalf G (1974) TRH: A possible mediator of thermoregulation. Nature 252:310–311Google Scholar
  26. Miyamoto M, Fukuda N, Narumi S, Nagai Y, Saji Y, Nagawa Y (1981) γ-Butyrolactone-γ-carbonyl-histidyl-prolineamide citrate (DN-1417): A novel TRH analog with potent effects on the central nervous system. Life Sci 28:861–869Google Scholar
  27. Miyamoto M, Narumi S, Nagai Y, Shima T, Nagawa Y (1979) Thyrotropin releasing hormone (TRH): Hyperactivity and mesolimbic dopamine system in rats. Jpn J Pharmacol 29:335–347Google Scholar
  28. Miyamoto M, Nagai Y, Narumi S, Saji Y, Nagawa Y (1982) TRH and its novel analog (DN-1417); antipentobarbital cation and involvement of cholinergic mechanisms. Pharmacol Biochem Behav 17:797–806Google Scholar
  29. Morley JE, Yamada T, Walsh JH, Lamers H, Wong H, Shulkes A, Damassa DA, Gordon J, Carlson HE, Hershman JM (1980) Morphine addiction and withdrawal alters brain peptide concentrations. Life Sci 26:2239–2244Google Scholar
  30. Plotnikoff NP, Prange AJ, Breese GR, Anderson MS, Wilson IC (1974) The effects of TRH on DOPA response in normal, hypophysectomized and thyroidectomized animals. In: Prange AJ (ed) The thyroid axis drugs and behavior. Raven Press, New York, pp 103–113Google Scholar
  31. Porter CC, Lotti VJ, De Felice MJ (1977) The effect of TRH and a related tripeptide, l-N-(2-oxopiperidin6-yl-carbonyl)-l-histidyl-l-thiazoline-4-carboxamide (MK-771, OHT) on the depressant action of barbiturates and alcohol in mice and rats. Life Sci 21:811–820Google Scholar
  32. Redding RW, Schally AV (1972) On the half life of thyrotropin releasing hormone in rats. Neuroendocrinology 9:250–256Google Scholar
  33. Simasko SM, Horita A (1982) Characterization and distribution of 3H-(3-MeHis2) thyrotropin releasing hormone receptors in rat brain. Life Sci 30:1793Google Scholar
  34. Tache Y, Lis M, Collu R (1977) Effects of thyrotropin releasing hormone on behavioral and hormonal changes induced by β-endorphin. Life Sci 21:841–846Google Scholar
  35. Way EL, Loh HH, Shen FH (1969) Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther 167:1–8Google Scholar
  36. Wei E, Tseng LF, Loh HH, Loh EL (1974) Morphine abstinence signs: similarity to thermoregulatory behavior. Nature 347:398–400Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • Hemendra N. Bhargava
    • 1
  • George A. Matwyshyn
    • 1
  1. 1.Department of PharmacodynamicsUniversity of Illinois at Chicago, Health Sciences CenterChicagoUSA

Personalised recommendations